|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$4,429,855
|
N/A
|
National Institutes of Health
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
$92,915
|
N/A
|
DCEG (NCI)
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$4,800
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$2,400
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$4,746
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$7,982
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$151,709
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
|
3UM1CA186704-04S1
|
$170,500
|
|
ABBRUZZESE, JAMES
|
DUKE UNIVERSITY
|
|
|
Linxian nutrition intervention trial follow-up study
|
ZIA CP000112-00377
|
$254,770
|
$12,738
|
Abnet, Christian
|
DCEG (NCI)
|
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112-10339
|
$94,675
|
$4,734
|
Abnet, Christian
|
DCEG (NCI)
|
|
|
Biologic specimen bank for early lung cancer markers in Chinese tin miners
|
ZIA CP000176-10338
|
$249,949
|
$249,949
|
Abnet, Christian
|
DCEG (NCI)
|
|
|
Aerobic Exercise for Smokers with Depressive Symptomatology
|
5R01CA173551-05
|
$509,755
|
$509,755
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
|
Giant Macrophage-like Cells as a blood-based Biomarker for Lung Cancer Recurrence
|
1R43CA206840-01A1
|
$182,850
|
$182,850
|
ADAMS, DANIEL
|
CREATV MICROTECH, INC.
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
$70,716
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
5U01CA190234-03
|
$667,641
|
$667,641
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-03
|
$778,713
|
$389,357
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
|
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer
|
4K00CA212455-03
|
$69,749
|
|
AFFRONTI, HAYLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Policy- and Provider-Level Determinants of Human Papillomavirus Vaccination Disparities Among Young U.S. Women
|
1K01CA234226-01
|
$158,403
|
|
AGENOR, MADINA
|
TUFTS UNIVERSITY MEDFORD
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
$15,494
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-04
|
$737,200
|
$73,720
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems
|
1R01CA227136-01A1
|
$454,956
|
|
AGHI, MANISH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
|
4R44CA203336-02
|
$659,516
|
|
AGUILAR-CORDOVA, ESTUARDO
|
ADVANTAGENE, INC
|
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S1
|
$54,859
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S2
|
$188,884
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
5R01CA172921-05
|
$357,673
|
$357,673
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-04
|
$1,367,856
|
$136,786
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
|
Unraveling Genetic Determinants of Lung Cancer Risk in African Americans
|
5K07CA172294-06
|
$160,123
|
$160,123
|
ALDRICH, MELINDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Clinical Support
|
ZIE BC 011653
|
$34,958
|
$29,715
|
Alewine, Christine
|
CCR (NCI)
|
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
7R01CA182076-05
|
$339,622
|
|
ALLEN, PETER
|
DUKE UNIVERSITY
|
|
|
Novel Strategies for Precision T-cell Therapies
|
3R01CA198095-03S1
|
$107,431
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
$23,836
|
Alter, Blanche
|
DCEG (NCI)
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$11,400
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$16,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$211,646
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
|
4R00CA204593-03
|
$249,000
|
$249,000
|
ALTMAN, BRIAN
|
UNIVERSITY OF ROCHESTER
|
|
|
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
|
7K99CA204593-02
|
$86,521
|
$86,521
|
ALTMAN, BRIAN
|
WISTAR INSTITUTE
|
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
3R01CA208042-03S1
|
$223,893
|
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$113,376
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Integrative analysis of lung cancer etiology and risk
|
1U19CA203654-01A1
|
$2,833,706
|
$2,833,706
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
|
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies
|
3U19CA203654-02S1
|
$147,830
|
$147,830
|
AMOS, CHRISTOPHER
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
|
3R01AR070234-04S1
|
$55,691
|
|
ANANDASABAPATHY, NIROSHANA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
|
Disruption of T cell tolerance in type 1 diabetes
|
3P01AI118688-03S1
|
$52,804
|
|
ANDERSON, MARK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
$9,108
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
$26,513
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
$28,090
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
$361,715
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
LGBT Adults and Tobacco Stigma: A Qualitative Study
|
5R01CA190238-03
|
$455,448
|
$455,448
|
ANTIN, TAMAR
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
3R01CA201124-02S1
|
$189,200
|
$189,200
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-02
|
$259,646
|
$259,646
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Total relevant funding to Lung for this search: $335,679,047
|
